Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Crinò L, Clerici M, Figoli F, Barduagni M, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F, et al. Crinò L, et al. Among authors: di costanzo f. Lung Cancer. 1995 Apr;12 Suppl 1:S125-32. doi: 10.1016/0169-5002(95)00428-4. Lung Cancer. 1995. PMID: 7551920 Clinical Trial.
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Crinò L, Clerici M, Figoli F, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F, Boni C, et al. Crinò L, et al. Among authors: di costanzo f. Ann Oncol. 1995 Apr;6(4):347-53. doi: 10.1093/oxfordjournals.annonc.a059183. Ann Oncol. 1995. PMID: 7619749 Free article. Clinical Trial.
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V, Cocconi G, Angelini F, Cavicchi F, Di Costanzo F, Gilli G, Rodinò C, Soldani M, Tonato M, Finardi C. De Lisi V, et al. Among authors: di costanzo f. Cancer. 1996 Jan 15;77(2):245-50. doi: 10.1002/(SICI)1097-0142(19960115)77:2<245::AID-CNCR4>3.0.CO;2-L. Cancer. 1996. PMID: 8625230 Clinical Trial.
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Crinò L, Scagliotti GV, Ricci S, De Marinis F, Rinaldi M, Gridelli C, Ceribelli A, Bianco R, Marangolo M, Di Costanzo F, Sassi M, Barni S, Ravaioli A, Adamo V, Portalone L, Cruciani G, Masotti A, Ferrara G, Gozzelino F, Tonato M. Crinò L, et al. Among authors: di costanzo f. J Clin Oncol. 1999 Nov;17(11):3522-30. doi: 10.1200/JCO.1999.17.11.3522. J Clin Oncol. 1999. PMID: 10550150 Clinical Trial.
5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
De Lisi V, Cocconi G, Tonato M, Di Costanzo F, Leonardi F, Soldani M. De Lisi V, et al. Among authors: di costanzo f. Recent Results Cancer Res. 1988;110:212-8. doi: 10.1007/978-3-642-83293-2_33. Recent Results Cancer Res. 1988. PMID: 3136519 Clinical Trial. No abstract available.
191 results